Evidence map›Paper›PMID 41934591›Full record

ArticleUpdates in surgery2026

Robotic surgical management of gallbladder cancer: comparing outcomes and feasibility of hepatectomy with or without bile duct resection and reconstruction.

Garnet Vanterpool, Roberta Odorizzi, Sharona B Ross, Hasan Al Harakeh, Kristina Milivojev Covilo, Henry Zhang, Iswanto Sucandy

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Garnet VanterpoolDigestive Health Institute Hepatopancreatobiliary (HPB) and Robotic Surgery, Division Chief of Hepatopancreatobiliary Surgery, 3000 Medical Park Drive, Suite # 500, Tampa, FL, 33613, USA.
Roberta OdorizziDigestive Health Institute Hepatopancreatobiliary (HPB) and Robotic Surgery, Division Chief of Hepatopancreatobiliary Surgery, 3000 Medical Park Drive, Suite # 500, Tampa, FL, 33613, USA.
Sharona B RossDigestive Health Institute Hepatopancreatobiliary (HPB) and Robotic Surgery, Division Chief of Hepatopancreatobiliary Surgery, 3000 Medical Park Drive, Suite # 500, Tampa, FL, 33613, USA.
Hasan Al HarakehDigestive Health Institute Hepatopancreatobiliary (HPB) and Robotic Surgery, Division Chief of Hepatopancreatobiliary Surgery, 3000 Medical Park Drive, Suite # 500, Tampa, FL, 33613, USA.
Kristina Milivojev CoviloDigestive Health Institute Hepatopancreatobiliary (HPB) and Robotic Surgery, Division Chief of Hepatopancreatobiliary Surgery, 3000 Medical Park Drive, Suite # 500, Tampa, FL, 33613, USA.
Henry ZhangDigestive Health Institute Hepatopancreatobiliary (HPB) and Robotic Surgery, Division Chief of Hepatopancreatobiliary Surgery, 3000 Medical Park Drive, Suite # 500, Tampa, FL, 33613, USA.
Iswanto SucandyDigestive Health Institute Hepatopancreatobiliary (HPB) and Robotic Surgery, Division Chief of Hepatopancreatobiliary Surgery, 3000 Medical Park Drive, Suite # 500, Tampa, FL, 33613, USA. iswanto_sucandy@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGallbladder cancer (GBC) is an aggressive malignancy, with surgery being the only curative option for resectable cases. Surgical approaches vary based on disease stage, ranging from cholecystectomy to extended liver resection and lymphadenectomy, with or without biliary resection. This study presents our experience of robotic surgery for GBC with and without biliary resection/reconstruction.

methodsA retrospective analysis was conducted on 38 patients who underwent robotic resection for GBC between February 2016 and November 2024. Beyond the standard partial segment 4B/5 resection and portal lymphadenectomy, the cohort was divided into two groups: common bile duct (CBD) resection and non-CBD resection group. Data are presented as median (mean ± SD).

resultsThe median age was 68 years (68 ± 11.49), with 71% women. Nineteen patients (50%) were diagnosed incidentally and required subsequent liver resection. Bile duct resection and Roux-en-Y hepaticojejunostomy were performed in 9 patients (23.7%), due to positive cystic duct margins. No conversions to open surgery occurred. Operative time was longer in the CBD resection group (470 vs. 219 min), which also had higher rates of vascular resection (33% vs. 3%), lymphovascular invasion (67% vs. 28%), and node-positive disease (67% vs. 24%), though the latter was not statistically significant. No differences were found in lymph node retrieval [6 (6.21 ± 4.58)], R0 resection rates (95%) or postoperative morbidity.

conclusionThe higher rates of lymphovascular invasion, vascular resections, and node-positive disease in the CBD resection group likely reflect more advanced disease. Robotic approach for GBC resection is feasible and safe, even when biliary and vascular resections are needed, offering an alternative minimally invasive technique to conventional open surgery.

Indexed as

Bile DuctsGallbladder NeoplasmsHepatectomyPlastic Surgery ProceduresRobotic Surgical ProceduresAgedFeasibility StudiesFemaleHumansLymph Node ExcisionMaleMiddle AgedOperative TimeRetrospective StudiesTreatment OutcomeBile duct resectionCholecystectomyGallbladder cancerRobotic hepatectomyRoux-en-Y hepaticojejunostomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.